HERZ
赫兹
ISSN: 0340-9937
自引率: 5.3%
发文量: 94
被引量: 1083
影响因子: 1.738
通过率: 暂无数据
出版周期: 双月刊
审稿周期: 2.14
审稿费用: 0
版面费用: 暂无数据
年文章数: 94
国人发稿量: 9

投稿须知/期刊简介:

HERZ is the high-level journal for further education for all physicians interested in cardiology. The individual issues of the journal each deal with specific topics and comprise review articles in English and German written by competent and esteemed authors. They provide up-to-date and comprehensive information concerning the speciality dealt with in the issue. Due to the fact that all relevant aspects of the pertinent topic of an issue are considered an overview of the current status and progress in cardiology is presented. Contributions concerning the latest developments and case reports round off the spectrum of information provided. Being the official organ of the German Federation of Cardiologists in Private Practice [Bundesverbandes Niedergelassener Kardiologen (BNK)] HERZ also informs on political topics concerning the profession and the contents of courses workshops etc. held by the federation. Cited in: Biological Abstracts (Biosis) - Current Contents/Clinical Medicine - DIMDI - EMBASE/Excerpta Medica - Healthstar - Index Medicus (Medline) - Science Citation Index (Scisearch). The abstracts of the articles appearing in the journal are also available online:

期刊描述简介:

HERZ is the high-level journal for further education for all physicians interested in cardiology. The individual issues of the journal each deal with specific topics and comprise review articles in English and German written by competent and esteemed authors. They provide up-to-date and comprehensive information concerning the speciality dealt with in the issue. Due to the fact that all relevant aspects of the pertinent topic of an issue are considered an overview of the current status and progress in cardiology is presented. Contributions concerning the latest developments and case reports round off the spectrum of information provided. Being the official organ of the German Federation of Cardiologists in Private Practice [Bundesverbandes Niedergelassener Kardiologen (BNK)] HERZ also informs on political topics concerning the profession and the contents of courses workshops etc. held by the federation. Cited in: Biological Abstracts (Biosis) - Current Contents/Clinical Medicine - DIMDI - EMBASE/Excerpta Medica - Healthstar - Index Medicus (Medline) - Science Citation Index (Scisearch). The abstracts of the articles appearing in the journal are also available online:

最新论文
  • [What is new in the management of peripheral arterial occlusive disease and diseases of the aorta? : Highlights of the ESC guidelines 2024].

    The European Society of Cardiology (ESC) guidelines on peripheral arterial disease (PAD) and diseases of the aorta published in September 2024 for the first time combine recommendations for both diseases in a joint guideline document. The consolidation of PAD and aorta guidelines follows a holistic approach, which underlines the entirety of the arterial vascular system. This aim is underlined by a specifically introduced recommendation to take the entirety of the circulatory system into account in patients with vascular diseases. The focus in the current ESC guideline document is on a multidisciplinary, patient-centered management of PAD and diseases of the aorta, whereby the prevention and follow-up of patients after therapeutic interventions are emphasized. In PAD the document highlights exercise training and the procedure for patients with chronic wounds as well as risk stratification and hereditary diseases of the aorta.

    被引量:- 发表:1970

  • [eCardiology].

    被引量:- 发表:1970

  • Acute atrial infarction: a relatively neglected and under-recognized entity in clinical practice.

    被引量:- 发表:1970

  • Efficacy of sacubitril-valsartan vs. angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in preventing atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis.

    被引量:- 发表:1970

  • Assessing the efficacy of renal denervation in patients with resistant arterial hypertension : Systematic review and meta-analysis.

    Renal denervation (RDN) is an innovative procedure designed to regulate the renal sympathetic nervous system for the control of arterial hypertension (HTN). RDN has emerged as an alternative for patients with resistant HTN. However, the clinical efficacy of RDN remains incompletely elucidated. PubMed, Embase, and Cochrane databases were searched for randomized controlled trials (RCTs) comparing the use of RDN with sham procedure or pharmacological treatment in patients with resistant HTN. Statistical analyses were performed using R Studio 4.3.2 (R Foundation for Statistical Computing, Vienna, Austria). Heterogeneity was examined with the Cochran Q test I2 statistics. Mean difference (MD) with 95% confidence interval (CI) were pooled across trials. P values of <0.05 were considered statistically significant. The primary outcomes of interest were changes from baseline in systolic blood pressure (SBP), diastolic blood pressure (DBP), and serum creatinine. Twenty-one RCTs comprising 3345 patients were included in this meta-analysis, whereby 2004 (59.91%) received renal denervation and 1341 (40.09%) received pharmacological treatment or sham procedure. Follow-up ranged from 2 to 48 months. Compared to control group, RDN significantly reduced SBP (MD -3.53 mm Hg; 95% CI -5.94 to -1.12; p = 0.004; I2 = 74%) and DBP (MD -1.48 mm Hg; 95% CI -2.56 to -0.40; p = 0.007; I2 = 51%). Regarding serum creatinine (MD -2.51; 95% CI -7.90 to 2.87; p = 0.36; I2 = 40%), there was no significant difference between RDN and control groups. In this meta-analysis of RCTs of patients with resistant HTN, RDN was associated with a reduction in SBP and DBP compared to sham procedure or pharmacological treatment.

    被引量:- 发表:1970

统计分析
是否有问题?您可以直接对期刊官方提问 提问

最近浏览

关于我们

zlive学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研工作者提供全面快捷的学术服务。在这里我们不忘初心,砥砺前行。

友情链接

联系我们

合作与服务

©2024 zlive学术声明使用前必读